Assessment
Questionnaire

Have a symptom?
See what questions
a doctor would ask.
 

Deaths from Amyloidosis

Survival rate statistics for Amyloidosis

The following are statistics from various sources about the survival rate for Amyloidosis:

  • 1 year is the median survival rate for patients who have a liver biopsy to treat amyloidosis in the US (Amyloidosis: Recognition, Prognosis and Conventional Therapy, American Society of Hematology)
  • Symptomatic congestive heart failure has a median survival of 4 to 6 months in the US (Amyloidosis: Recognition, Prognosis and Conventional Therapy, American Society of Hematology)
  • 8 months is the median survival for amyloidosis patients from the onset of myelodysplasia in the US (Amyloidosis: Recognition, Prognosis and Conventional Therapy, American Society of Hematology)
  • Amyloid patients with cardiac involvement who undergo heart transplant have a 100% 1 year survival rate in the US (Amyloidosis: Recognition, Prognosis and Conventional Therapy, American Society of Hematology)
  • Amyloid patients with cardiac involvement who undergo heart transplant have a 83.3% 2 year survival rate in the US (Amyloidosis: Recognition, Prognosis and Conventional Therapy, American Society of Hematology)
  • The five year survival rate for secondary AA Amyloidosis is about 50% in the US (Amloidosis Support Network)
  • The 1 year survival rate for patients with primary systemic amyloidosis who undergo peripheral blood stem cell transplantation is 89% (Blood. 2004;103:3960-3963, The American Society of Hematology)
  • The 1 year survival rate for patients with primary systemic amyloidosis who donít undergo peripheral blood stem cell transplantation is 55% (Blood. 2004;103:3960-3963, The American Society of Hematology)
  • The 2 year survival rate for patients with primary systemic amyloidosis who undergo peripheral blood stem cell transplantation is 71% (Blood. 2004;103:3960-3963, The American Society of Hematology)
  • The 2 year survival rate for patients with primary systemic amyloidosis who donít undergo peripheral blood stem cell transplantation is 71% (Blood. 2004;103:3960-3963, The American Society of Hematology)
  • The 4 year survival rate for patients with primary systemic amyloidosis who undergo peripheral blood stem cell transplantation is 81% ((Blood. 2004;103:3960-3963, The American Society of Hematology)
  • The 4 year survival rate for patients with primary systemic amyloidosis who donít undergo peripheral blood stem cell transplantation is 41% (Blood. 2004;103:3960-3963, The American Society of Hematology)
  • The median survival rate for AL amyloidosis is 12-18 months in the US (The Mayo Clinic)
  • 51% is the 1 year survival rate for patients with AL Amyloidosis (Long-Term Survival in 30 Patients With Primary Amyloidosis, The American Society of Hematology, 1999)
  • 16% is the 5 year survival rate for patients with AL Amyloidosis (Long-Term Survival in 30 Patients With Primary Amyloidosis, The American Society of Hematology, 1999)
  • 4.7% is the 10 year survival rate for patients with AL Amyloidosis (Long-Term Survival in 30 Patients With Primary Amyloidosis, The American Society of Hematology, 1999)
  • 100% of AL amyloidosis patients who survived more than 10 years had received alkylating-agent therapy (Long-Term Survival in 30 Patients With Primary Amyloidosis, The American Society of Hematology, 1999)

Death statistics for Amyloidosis

The following are statistics from various sources about deaths and Amyloidosis:

  • 35% of deaths from secondary AA amyloidosis is due to end-stage renal failure resulting from untreated secondary AA amyloidosis n the US (Amyloidosis Support Network)

Amyloidosis: Hospitalization Statistics

The following are statistics from various sources about hospitalizations and Amyloidosis:

  • 0.008% (995) of hospital consultant episodes were for amyloidosis in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 86% of hospital consultant episodes for amyloidosis required hospital admission in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 57% of hospital consultant episodes for amyloidosis were for men in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 43% of hospital consultant episodes for amyloidosis were for women in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 23% of hospital consultant episodes for amyloidosis required emergency hospital admission in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • more stats »

Premium articles about Death:

This section lists our premium articles on topics related to death. These are original authored articles on topics of great interest:

 

By using this site you agree to our Terms of Use. Information provided on this site is for informational purposes only; it is not intended as a substitute for advice from your own medical team. The information on this site is not to be used for diagnosing or treating any health concerns you may have - please contact your physician or health care professional for all your medical needs. Please see our Terms of Use.

Home | Symptoms | Diseases | Diagnosis | Videos | Tools | Forum | About Us | Terms of Use | Privacy Policy | Site Map | Advertise